Skip to main content

Partner-Enabled Capabilities

Partner-enabled support across the peptide value chain.

Bring us the requirement, the available information, and the unanswered questions. We help qualified organizations structure an appropriate pathway across selected peptide sourcing, development, manufacturing, packaging, and supply partners.

We coordinate these capabilities. The applicable qualified partner performs the specialized manufacturing, laboratory, development, packaging, or logistics work.

Conceptual project pathway progressing through defined coordination and review checkpoints.

The Value Chain

From requirement to coordinated supply.

  1. 01

    Source

    Identify potential Peptide API sources and coordinate manufacturer, facility, documentation, technical, and commercial review.

  2. 02

    Develop

    Explore custom peptide synthesis, formulation, analytical development, process development, scale-up, and qualified project planning.

  3. 03

    Manufacture

    Coordinate appropriate peptide development, production, fill-and-finish, packaging, and release capabilities through selected partners.

  4. 04

    Deliver

    Align peptide documentation, packaging, project communication, logistics planning, and continuing supply support.

Capability Areas

Specialized pathways for qualified peptide projects.

Coordination of Peptide API, research-use Peptide API, custom-development, manufacturer, documentation, quotation, and supply pathways for qualified peptide projects.

  • Peptide APIs
  • Research-use Peptide APIs
  • Custom peptide synthesis coordination
  • Manufacturer and facility review
  • Documentation, specification, and Certificate of Analysis coordination
  • Quotation and continuing peptide supply planning

Manufacturing-partner review may consider documented United States Food and Drug Administration (FDA) inspection histories and available evidence relevant to applicable Current Good Manufacturing Practice (CGMP) requirements.

Inspection and quality-system information is evaluated by entity, facility, applicable scope, status, and date. These records do not constitute product approval or guarantee current compliance.

RED BioMed's Role

One coordinated pathway across multiple specialized capabilities.

  1. Stage 1

    Structure

    Define the organization, requirement, intended use, market, documentation needs, commercial scope, and project objectives.

  2. Stage 2

    Coordinate

    Identify potential partner pathways and align technical, quality, documentation, packaging, timing, and commercial discussions.

  3. Stage 3

    Advance

    Support qualified progression into confidentiality, technical review, quotation, planning, production, and supply where appropriate.

RED BioMed does not replace the legal, regulatory, quality, technical, or professional responsibilities of the manufacturer, buyer, importer, distributor, pharmacy, practitioner, or other project participant.

Project Fit

Designed for qualified organizations with defined peptide requirements.

Peptide and Compounding

  • Peptide manufacturers and compounders
  • 503A traditional compounding pharmacies
  • 503B outsourcing facilities

Research and Development

  • Research laboratories
  • Universities
  • Peptide-development organizations

Commercialization

  • Healthcare and peptide-focused brands
  • Private-label organizations
  • Authorized commercial partners

Distribution and Market Access

  • Licensed distributors
  • Licensed wholesalers
  • Authorized importers
  • Qualified regional partners

Every opportunity remains subject to organization qualification, technical feasibility, partner availability, documentation, intended use, destination market, and applicable requirements.